Italia markets open in 17 minutes
Dow Jones
39.112,16 -299,05 (-0,76%) Nasdaq
17.717,65 +220,84 (+1,26%) Nikkei 225
39.667,07 +493,92 (+1,26%) EUR/USD
1,0700 -0,0016 (-0,15%) Bitcoin EUR
57.524,50 +385,02 (+0,67%) CMC Crypto 200
1.278,91 -4,88 (-0,38%)
Enveric Biosciences Inc (SLZA.MU)
Munich - Munich Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
In data: 08:03AM CEST. Mercato aperto.
| Chiusura precedente | 0,6090 |
| Aperto | 0,5930 |
| Denaro | 0,5650 x N/D |
| Domanda | 0,5930 x N/D |
| Min-Max giorno | 0,5930 - 0,5930 |
| Intervallo di 52 settimane | 0,5860 - 3,1600 |
| Volume | |
| Media Volume | 0 |
| Capitalizzazione | N/D |
| Beta (mensile su 5 anni) | N/D |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | N/D |
| Prossima data utili | 12 ago 2024 - 16 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
Diamond Equity Research Initiates Coverage on Enveric Biosciences Inc. (NASDAQ: ENVB)
NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Enveric Biosciences Inc. (NASDAQ: ENVB). The in-depth 23-page initiation report includes detailed information on the Enveric Bioscience’s business model, services, industry, valuation, management, and risks. The full research report is available here. Highlights from the report include: Second Wave of Psychedelics, Reg
© 2024 Yahoo. Tutti i diritti riservati.